Clinical Trial Update: Zilganersen Expanded Access Program for Individuals With Alexander Disease

View source ↗

Summary

The document discusses an expanded access program for Zilganersen to treat Alexander disease, sponsored by Ionis Pharmaceuticals. The program status is AVAILABL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alexander Disease

Drugs mentioned

• Zilganersen

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Alexander Disease | Status: AVAILABLE